Combined measurement of N-terminal pro-B-type natriuretic peptide and highly sensitive cardiac troponin T for diagnosis and monitoring of heart injury in chronic Chagas' disease

Clinical Biochemistry

Volumn 46, Issue 15, 2013, Pages 1615-1618

  Munoz Saravia, Silvia Gilka ^a   Haberland, Annekathrin ^a   Bartel, Sabine ^b   Araujo, Raul ^c   Valda, Gregorio ^c   Reynaga, Diana Duchen ^c   Ramirez, Ivan Diaz ^a   Borges, Adrian C ^d   Wallukat, Gerd ^b   Ziebig, Reinhard ^a   Schimke, Ingolf ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c Santa Barbara Hospital Sucre   (Bolivia)

^d HELIOS KLINIKUM EMIL VON BEHRING   (Germany)

Author keywords

B type natriuretic peptides; Cardiac troponins; Cardiomyopathy; Chagas' heart disease; Chronic Chagas' disease; Hs cTnT; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T;

ADULT; ARTICLE; CARDIOMYOPATHY; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HEART INJURY; HUMAN; LABORATORY TEST; MALE; MEASUREMENT; PATIENT MONITORING; PREDICTIVE VALUE; PRIORITY JOURNAL;

B-TYPE NATRIURETIC PEPTIDES; CARDIAC TROPONINS; CARDIOMYOPATHY; CHAGAS' HEART DISEASE; CHRONIC CHAGAS' DISEASE; HS-CTNT; NT-PROBNP;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TROPONIN T;

EID: 84884354242     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.06.011     Document Type: Article

References (17)

1. Munoz-Saravia S.G., Haberland A., Wallukat G., Schimke I. Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine. Heart Fail Rev 2012, 17:45-64.
2. Thygesen K., Mair J., Mueller C., Huber K., Weber M., Plebani M., et al. Recommendations for the use of natriuretic peptides in acute cardiac care. A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J 2012, 33:2001-2006.
3. McMurray J.J., Adamopoulos S., Anker S.D., Auricchio A., Böhm M., Dickstein K., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012, 33:1787-1847.
4. Thygesen K., Alpert J.S., White H.D., Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction. Circulation 2007, 116:2634-2653.
5. Januzzi J.L., Filippatos G., Nieminen M., Gheorghiade M. Troponin elevation in patients with heart failure: on behalf of the third universal definition of Myocardial Infarction Global Task Force: heart failure section. Eur Heart J 2012, 33:2265-2271.
6. Nagarajan V., Hernandez A.V., Tang W.H. Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart 2012, 98:1778-1786.
7. Wallukat G., Munoz Saravia S.G., Haberland A., Bartel S., Araujo R., Valda G., et al. Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients. J Am Coll Cardiol 2010, 55:463-468.
8. Saravia S.G., Haberland A., Bartel S., Araujo R., Valda G., Reynaga D.D., et al. Cardiac troponin T measured with a highly sensitive assay for diagnosis and monitoring of heart injury in chronic Chagas disease. Arch Pathol Lab Med 2011, 135:243-248.
9. Hallermayer K., Jarausch J., Menassanch-Volker S., Zaugg C., Ziegler A. Letter to the editor. Clin Chem 2013, 59:572-574.
10. Haberland A., Saravia S.G., Wallukat G., Ziebig R., Schimke I. Chronic Chagas disease: from basics to laboratory medicine. Clin Chem Lab Med 2013, 51:271-294.
11. Nadir M.A., Rekhraj S., Wei L., Lim T.K., Davidson J., MacDonald T.M., et al. Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease. J Am Coll Cardiol 2012, 60:960-968.
12. Jaffe A.S., Babuin L., Apple F.S. Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 2006, 48:1-11.
13. Tsai S.H., Lin Y.Y., Chu S.J., Hsu C.W., Cheng S.M. Interpretation and use of natriuretic peptides in non-congestive heart failure settings. Yonsei Med J 2010, 51:151-163.
14. Body R., Carley S., McDowell G., Jaffe A.S., France M., Cruickshank K., et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol 2011, 58:1332-1339.
15. Peacock F. The value of nothing. The consequence of a negative troponin test. Am Coll Cardiol 2011, 58:1340-1342.
16. Peter A., Kavsak P.A., Worster A. Dichotomizing high-sensitivity cardiac troponin T results and important analytical considerations. J Am Coll Cardiol 2012, 59:1570.
17. Munoz Saravia S.G., Haberland A., Bartel S., Araujo R., Valda G., Duchen D., et al. Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon: their potential impact for early risk assessment in asymptomatic Chagas' patients. J Am Coll Cardiol 2010, 56:526-527.